Aimed Bio Inc. (KOSDAQ:0009K0)
25,450
+3,100 (13.87%)
At close: Oct 1, 2026
Aimed Bio Market Cap
Aimed Bio has a market cap or net worth of 1.65 trillion as of October 1, 2026.
Market Cap
1.65T
Enterprise Value
1.55T
Revenue
66.79B
Ranking
n/a
PE Ratio
43.23
Stock Price
25,450.00
ChartMarket Cap Chart
Since December 4, 2025, Aimed Bio's market cap has decreased from 2.82T to 1.65T, a decrease of -41.69%. That is a compound annual growth rate of -48.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.65T | -55.46% |
| Dec 30, 2025 | 3.70T | 30.91% |
| Dec 4, 2025 | 2.82T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JS Link | 1.03T |
| Qurient | 874.29B |
| Rznomics | 670.22B |
| AprilBio | 514.15B |
| ROKIT Healthcare | 475.78B |
| Curocell | 329.67B |
| Inventage Lab | 316.06B |
| HansBiomed | 300.20B |